<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE collection SYSTEM "BioC.dtd">
<collection><source>GO_Annotation</source><date>20130316</date><key>go_annotation.key</key><document><id>23577128</id><passage><infon key="type">paragraph</infon><offset>20084</offset><annotation id="23577128_1"><infon key="gene">unc-29(172703)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="23397" length="60"/><text>did not reverse in response to the light flash and continued</text></annotation><annotation id="23577128_2"><infon key="gene">acr-16(179235)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="64823" length="70"/><text>Measurement of the Distance Moved in Response to ChR2-mediated PVY+PVX</text></annotation><annotation id="23577128_3"><infon key="gene">acr-18(191604)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="64823" length="70"/><text>Measurement of the Distance Moved in Response to ChR2-mediated PVY+PVX</text></annotation></passage><passage><infon key="type">paragraph</infon><offset>30878</offset><annotation id="23577128_4"><infon key="gene">acr-18(191604)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IMP</infon><infon key="type">GOA</infon><location offset="31802" length="165"/><text>Mutations in three of these genes (acr-18, unc-29 and acr-16) disrupted reversal behavior and are discussed below (for other mutant combinations tested see Fig. S2).</text></annotation><annotation id="23577128_5"><infon key="gene">unc-29(172703)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IMP</infon><infon key="type">GOA</infon><location offset="31802" length="165"/><text>Mutations in three of these genes (acr-18, unc-29 and acr-16) disrupted reversal behavior and are discussed below (for other mutant combinations tested see Fig. S2).</text></annotation><annotation id="23577128_6"><infon key="gene">acr-16(179235)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IMP</infon><infon key="type">GOA</infon><location offset="31802" length="165"/><text>Mutations in three of these genes (acr-18, unc-29 and acr-16) disrupted reversal behavior and are discussed below (for other mutant combinations tested see Fig. S2).</text></annotation></passage><passage><infon key="type">paragraph</infon><offset>31968</offset><annotation id="23577128_7"><infon key="gene">acr-18(191604)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IMP</infon><infon key="type">GOA</infon><location offset="31968" length="93"/><text>In acr-18 null mutants, only 28% of males reverse in response to PVY+PVX activation (Fig. 4).</text></annotation><annotation id="23577128_8"><infon key="gene">acr-18(191604)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IMP</infon><infon key="type">GOA</infon><location offset="32373" length="296"/><text>To determine whether the absence of acr-18 function specifically in the backward command cells was responsible for the mutant reversal defect, we targeted expression of a wild type acr-18 transgene to AVA in acr-18 mutant males and asked whether this was sufficient to rescue the reversal defect.</text></annotation><annotation id="23577128_9"><infon key="gene">acr-18(191604)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IMP</infon><infon key="type">GOA</infon><location offset="33271" length="330"/><text>We observed that the presence of the acr-18(+) transgene in the nmr-1-expressing cells was sufficient to rescue the acr-18 mutant defect: 76% of acr-18 males carrying the rescuing transgene in AVA reversed in response to PVY+PVX activation, whereas only 28% of acr-18 control males, which lacked this transgene, reversed (Fig. 4).</text></annotation><annotation id="23577128_10"><infon key="gene">acr-18(191604)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">NONE</infon><infon key="type">GOA</infon><location offset="33602" length="238"/><text>These data suggest that PVY+PVX-induced reversal depends on an ACR-18-containing cholinergic receptor that functions in nmr-1-expressing cells, most likely the backward command cells as these are direct targets of cholinergic PVY and PVX.</text></annotation></passage><passage><infon key="type">paragraph</infon><offset>34647</offset><annotation id="23577128_11"><infon key="gene">acr-18(191604)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IMP</infon><infon key="type">GOA</infon><location offset="34647" length="180"/><text>While the absence of acr-18 function in AVA significantly impairs reversal behavior in our ChR2 assays, acr-18 male populations can still reverse at an appreciable frequency (28%).</text></annotation><annotation id="23577128_12"><infon key="gene">acr-16(179235)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IMP</infon><infon key="type">GOA</infon><location offset="34907" length="226"/><text>Loss of acr-16 function alone, or in combination with acr-18 mutations, caused a modest, but not significant, decrease in reversal frequency, suggesting that acr-16 contributes to reversal response but is not pivotal (Fig. 4).</text></annotation><annotation id="23577128_13"><infon key="gene">acr-16(179235)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="34907" length="226"/><text>Loss of acr-16 function alone, or in combination with acr-18 mutations, caused a modest, but not significant, decrease in reversal frequency, suggesting that acr-16 contributes to reversal response but is not pivotal (Fig. 4).</text></annotation><annotation id="23577128_14"><infon key="gene">acr-18(191604)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="34907" length="226"/><text>Loss of acr-16 function alone, or in combination with acr-18 mutations, caused a modest, but not significant, decrease in reversal frequency, suggesting that acr-16 contributes to reversal response but is not pivotal (Fig. 4).</text></annotation><annotation id="23577128_15"><infon key="gene">acr-16(179235)</infon><infon key="go-term">vulval location|GO:0034608</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="35423" length="227"/><text>During our analyses of unc-29; acr-16 spicule insertion behavior, we noticed that double mutant males exhibit reduced scanning speed during the vulva search, a phenotype also exhibited by PVY-ablated males (Fig. 2C) [37], [39].</text></annotation><annotation id="23577128_16"><infon key="gene">unc-29(172703)</infon><infon key="go-term">vulval location|GO:0034608</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="35423" length="227"/><text>During our analyses of unc-29; acr-16 spicule insertion behavior, we noticed that double mutant males exhibit reduced scanning speed during the vulva search, a phenotype also exhibited by PVY-ablated males (Fig. 2C) [37], [39].</text></annotation><annotation id="23577128_17"><infon key="gene">unc-29(172703)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="36652" length="161"/><text>In the PVY+PVX artificial activation assays, the muscle-rescued unc-29; acr-16 males showed impaired reversal response with only 31% of males reversing (Fig. 4).</text></annotation><annotation id="23577128_18"><infon key="gene">acr-16(179235)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="36652" length="161"/><text>In the PVY+PVX artificial activation assays, the muscle-rescued unc-29; acr-16 males showed impaired reversal response with only 31% of males reversing (Fig. 4).</text></annotation><annotation id="23577128_19"><infon key="gene">acr-16(179235)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="36814" length="120"/><text>Thus, unc-29 loss of function significantly enhances the severity of reversal defects caused by loss of acr-16 function.</text></annotation><annotation id="23577128_20"><infon key="gene">unc-29(172703)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="36814" length="120"/><text>Thus, unc-29 loss of function significantly enhances the severity of reversal defects caused by loss of acr-16 function.</text></annotation><annotation id="23577128_21"><infon key="gene">acr-16(179235)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="37058" length="216"/><text>To test whether the absence of unc-29 function from AVA might be responsible for the reversal defect of unc-29; acr-16 males, we performed tissue-specific rescue experiments, targeting expression of unc-29(+) to AVA.</text></annotation><annotation id="23577128_22"><infon key="gene">unc-29(172703)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="37058" length="216"/><text>To test whether the absence of unc-29 function from AVA might be responsible for the reversal defect of unc-29; acr-16 males, we performed tissue-specific rescue experiments, targeting expression of unc-29(+) to AVA.</text></annotation><annotation id="23577128_23"><infon key="gene">unc-29(172703)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="37381" length="240"/><text>In ChR2-mediated PVY+PVX activation assays, unc-29; acr-16 males expressing unc-29(+) in AVA (indicated by GFP expression in AVA) were rescued, reversing at frequencies comparable to acr-16 single mutants and wild type males (83%) (Fig. 4).</text></annotation><annotation id="23577128_24"><infon key="gene">acr-16(179235)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="37381" length="240"/><text>In ChR2-mediated PVY+PVX activation assays, unc-29; acr-16 males expressing unc-29(+) in AVA (indicated by GFP expression in AVA) were rescued, reversing at frequencies comparable to acr-16 single mutants and wild type males (83%) (Fig. 4).</text></annotation><annotation id="23577128_25"><infon key="gene">acr-16(179235)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="37911" length="270"/><text>As the magnitude of reversals in unc-29(+)-rescued double mutants was consistently less than that of acr-16 single mutant males, unc-29(+) may be additionally required in cells downstream of the command cells to enhance the magnitude of backward movement once initiated.</text></annotation><annotation id="23577128_26"><infon key="gene">unc-29(172703)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="37911" length="270"/><text>As the magnitude of reversals in unc-29(+)-rescued double mutants was consistently less than that of acr-16 single mutant males, unc-29(+) may be additionally required in cells downstream of the command cells to enhance the magnitude of backward movement once initiated.</text></annotation></passage><passage><infon key="type">paragraph</infon><offset>38182</offset><annotation id="23577128_27"><infon key="gene">acr-16(179235)</infon><infon key="go-term">synaptic transmission, cholinergic|GO:0007271</infon><infon key="goevidence">NONE</infon><infon key="type">GOA</infon><location offset="38182" length="144"/><text>The data above suggest that unc-29, acr-16 and acr-18 act in AVA to mediate PVY/PVX-to-AVA cholinergic transmission but are partially redundant.</text></annotation><annotation id="23577128_28"><infon key="gene">acr-18(191604)</infon><infon key="go-term">synaptic transmission, cholinergic|GO:0007271</infon><infon key="goevidence">NONE</infon><infon key="type">GOA</infon><location offset="38182" length="144"/><text>The data above suggest that unc-29, acr-16 and acr-18 act in AVA to mediate PVY/PVX-to-AVA cholinergic transmission but are partially redundant.</text></annotation><annotation id="23577128_29"><infon key="gene">unc-29(172703)</infon><infon key="go-term">synaptic transmission, cholinergic|GO:0007271</infon><infon key="goevidence">NONE</infon><infon key="type">GOA</infon><location offset="38182" length="144"/><text>The data above suggest that unc-29, acr-16 and acr-18 act in AVA to mediate PVY/PVX-to-AVA cholinergic transmission but are partially redundant.</text></annotation><annotation id="23577128_30"><infon key="gene">unc-29(172703)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="38476" length="169"/><text>We observed that this was in fact the case: only 4% of unc-29; acr-16 acr-18 triple mutant males reversed in response to PVY+PVX activation with ChR2 (Fig. 4, Video S7).</text></annotation><annotation id="23577128_31"><infon key="gene">acr-16(179235)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="38476" length="169"/><text>We observed that this was in fact the case: only 4% of unc-29; acr-16 acr-18 triple mutant males reversed in response to PVY+PVX activation with ChR2 (Fig. 4, Video S7).</text></annotation><annotation id="23577128_32"><infon key="gene">acr-18(191604)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="38476" length="169"/><text>We observed that this was in fact the case: only 4% of unc-29; acr-16 acr-18 triple mutant males reversed in response to PVY+PVX activation with ChR2 (Fig. 4, Video S7).</text></annotation><annotation id="23577128_33"><infon key="gene">unc-29(172703)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="38476" length="348"/><text>We observed that this was in fact the case: only 4% of unc-29; acr-16 acr-18 triple mutant males reversed in response to PVY+PVX activation with ChR2 (Fig. 4, Video S7). This mutant phenotype, together with the tissue-specific rescue data, support a model in which PVY/PVX-to-AVA transmission is mediated by three partially redundant AChR subunits.</text></annotation><annotation id="23577128_34"><infon key="gene">acr-16(179235)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="38476" length="348"/><text>We observed that this was in fact the case: only 4% of unc-29; acr-16 acr-18 triple mutant males reversed in response to PVY+PVX activation with ChR2 (Fig. 4, Video S7). This mutant phenotype, together with the tissue-specific rescue data, support a model in which PVY/PVX-to-AVA transmission is mediated by three partially redundant AChR subunits.</text></annotation><annotation id="23577128_35"><infon key="gene">acr-18(191604)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="38476" length="348"/><text>We observed that this was in fact the case: only 4% of unc-29; acr-16 acr-18 triple mutant males reversed in response to PVY+PVX activation with ChR2 (Fig. 4, Video S7). This mutant phenotype, together with the tissue-specific rescue data, support a model in which PVY/PVX-to-AVA transmission is mediated by three partially redundant AChR subunits.</text></annotation></passage><passage><infon key="type">title_2</infon><offset>38887</offset><annotation id="23577128_36"><infon key="gene">unc-29(172703)</infon><infon key="go-term">vulval location|GO:0034608</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="38887" length="82"/><text>Cholinergic Receptor Mutants Exhibit Defects in Locomotion during the Vulva Search</text></annotation><annotation id="23577128_37"><infon key="gene">acr-16(179235)</infon><infon key="go-term">vulval location|GO:0034608</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="39330" length="243"/><text>unc-29; acr-16 double mutants also performed this behavior reasonably well although showed reduced scanning speed as previously reported [37] (median scanning speed = 150 microm/sec cf. wild type control male median = 180 microm/sec, Fig. 5). </text></annotation><annotation id="23577128_38"><infon key="gene">unc-29(172703)</infon><infon key="go-term">vulval location|GO:0034608</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="38887" length="82"/><text>Cholinergic Receptor Mutants Exhibit Defects in Locomotion during the Vulva Search</text></annotation><annotation id="23577128_39"><infon key="gene">acr-16(179235)</infon><infon key="go-term">vulval location|GO:0034608</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="40476" length="311"/><text>unc-29; acr-16 acr-18 mutants had a median contact response efficiency of 50% (cf. 50% for the -PVY-PVX treatment, Fig. 2), a median scanning speed of 140 microm/sec (cf. 110 microm/sec for the -PVY-PVX treatment) and a median loss of contact frequency of 2 (cf. 8 for the -PVY-PVX treatment) (Fig. 2, Fig. 5). </text></annotation><annotation id="23577128_40"><infon key="gene">acr-18(191604)</infon><infon key="go-term">vulval location|GO:0034608</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="40476" length="311"/><text>unc-29; acr-16 acr-18 mutants had a median contact response efficiency of 50% (cf. 50% for the -PVY-PVX treatment, Fig. 2), a median scanning speed of 140 microm/sec (cf. 110 microm/sec for the -PVY-PVX treatment) and a median loss of contact frequency of 2 (cf. 8 for the -PVY-PVX treatment) (Fig. 2, Fig. 5). </text></annotation></passage><passage><infon key="type">paragraph</infon><offset>38970</offset><annotation id="23577128_41"><infon key="gene">acr-18(191604)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IMP</infon><infon key="type">GOA</infon><location offset="39098" length="231"/><text>Surprisingly, we found that although more than 50% of acr-18 single mutants are defective in reversal behavior in the ChR2 assays, acr-18 males were superficially wild type for backward locomotion in the context of mating (Fig. 5).</text></annotation><annotation id="23577128_42"><infon key="gene">unc-29(172703)</infon><infon key="go-term">vulval location|GO:0034608</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="39573" length="246"/><text>The fact that unc-29; acr-16 mutants are affected in vulva search locomotion speed, and acr-18 mutants are not, suggests that unc-29 and acr-16 encoded channels may be more critical in determining locomotory speed than the acr-18 encoded channel.</text></annotation><annotation id="23577128_43"><infon key="gene">acr-16(179235)</infon><infon key="go-term">vulval location|GO:0034608</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="39573" length="246"/><text>The fact that unc-29; acr-16 mutants are affected in vulva search locomotion speed, and acr-18 mutants are not, suggests that unc-29 and acr-16 encoded channels may be more critical in determining locomotory speed than the acr-18 encoded channel.</text></annotation><annotation id="23577128_44"><infon key="gene">unc-29(172703)</infon><infon key="go-term">vulval location|GO:0034608</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="40147" length="221"/><text>Consistent with this possibility, males mutant for all three receptor genes (unc-29; acr-16 acr-18 triple mutants) were significantly affected in all aspects of vulva search locomotion that we measured (Fig. 5; Video S8).</text></annotation><annotation id="23577128_45"><infon key="gene">acr-16(179235)</infon><infon key="go-term">vulval location|GO:0034608</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="40147" length="221"/><text>Consistent with this possibility, males mutant for all three receptor genes (unc-29; acr-16 acr-18 triple mutants) were significantly affected in all aspects of vulva search locomotion that we measured (Fig. 5; Video S8).</text></annotation><annotation id="23577128_46"><infon key="gene">acr-18(191604)</infon><infon key="go-term">vulval location|GO:0034608</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="40147" length="221"/><text>Consistent with this possibility, males mutant for all three receptor genes (unc-29; acr-16 acr-18 triple mutants) were significantly affected in all aspects of vulva search locomotion that we measured (Fig. 5; Video S8).</text></annotation><annotation id="23577128_47"><infon key="gene">unc-29(172703)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="40476" length="513"/><text>unc-29; acr-16 acr-18 mutants had a median contact response efficiency of 50% (cf. 50% for the -PVY-PVX treatment, Fig. 2), a median scanning speed of 140 microm/sec (cf. 110 microm/sec for the -PVY-PVX treatment) and a median loss of contact frequency of 2 (cf. 8 for the -PVY-PVX treatment) (Fig. 2, Fig. 5). The similarity of the triple mutant to cell-ablated males is consistent with the ChR2 assay data, which argues that eliminating all three receptors essentially blocks PVY+PVX-induced backward movement. </text></annotation><annotation id="23577128_48"><infon key="gene">acr-16(179235)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="40476" length="513"/><text>unc-29; acr-16 acr-18 mutants had a median contact response efficiency of 50% (cf. 50% for the -PVY-PVX treatment, Fig. 2), a median scanning speed of 140 microm/sec (cf. 110 microm/sec for the -PVY-PVX treatment) and a median loss of contact frequency of 2 (cf. 8 for the -PVY-PVX treatment) (Fig. 2, Fig. 5). The similarity of the triple mutant to cell-ablated males is consistent with the ChR2 assay data, which argues that eliminating all three receptors essentially blocks PVY+PVX-induced backward movement. </text></annotation><annotation id="23577128_49"><infon key="gene">acr-18(191604)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="40476" length="513"/><text>unc-29; acr-16 acr-18 mutants had a median contact response efficiency of 50% (cf. 50% for the -PVY-PVX treatment, Fig. 2), a median scanning speed of 140 microm/sec (cf. 110 microm/sec for the -PVY-PVX treatment) and a median loss of contact frequency of 2 (cf. 8 for the -PVY-PVX treatment) (Fig. 2, Fig. 5). The similarity of the triple mutant to cell-ablated males is consistent with the ChR2 assay data, which argues that eliminating all three receptors essentially blocks PVY+PVX-induced backward movement. </text></annotation><annotation id="23577128_36"><infon key="gene">unc-29(172703)</infon><infon key="go-term">vulval location|GO:0034608</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="39330" length="243"/><text>unc-29; acr-16 double mutants also performed this behavior reasonably well although showed reduced scanning speed as previously reported [37] (median scanning speed = 150 microm/sec cf. wild type control male median = 180 microm/sec, Fig. 5). </text></annotation><annotation id="23577128_50"><infon key="gene">acr-16(179235)</infon><infon key="go-term">vulval location|GO:0034608</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="39330" length="243"/><text>unc-29; acr-16 double mutants also performed this behavior reasonably well although showed reduced scanning speed as previously reported [37] (median scanning speed = 150 microm/sec cf. wild type control male median = 180 microm/sec, Fig. 5). </text></annotation><annotation id="23577128_38"><infon key="gene">unc-29(172703)</infon><infon key="go-term">vulval location|GO:0034608</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="40476" length="311"/><text>unc-29; acr-16 acr-18 mutants had a median contact response efficiency of 50% (cf. 50% for the -PVY-PVX treatment, Fig. 2), a median scanning speed of 140 microm/sec (cf. 110 microm/sec for the -PVY-PVX treatment) and a median loss of contact frequency of 2 (cf. 8 for the -PVY-PVX treatment) (Fig. 2, Fig. 5). </text></annotation><annotation id="23577128_51"><infon key="gene">acr-16(179235)</infon><infon key="go-term">vulval location|GO:0034608</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="40476" length="311"/><text>unc-29; acr-16 acr-18 mutants had a median contact response efficiency of 50% (cf. 50% for the -PVY-PVX treatment, Fig. 2), a median scanning speed of 140 microm/sec (cf. 110 microm/sec for the -PVY-PVX treatment) and a median loss of contact frequency of 2 (cf. 8 for the -PVY-PVX treatment) (Fig. 2, Fig. 5). </text></annotation><annotation id="23577128_52"><infon key="gene">acr-18(191604)</infon><infon key="go-term">vulval location|GO:0034608</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="40476" length="311"/><text>unc-29; acr-16 acr-18 mutants had a median contact response efficiency of 50% (cf. 50% for the -PVY-PVX treatment, Fig. 2), a median scanning speed of 140 microm/sec (cf. 110 microm/sec for the -PVY-PVX treatment) and a median loss of contact frequency of 2 (cf. 8 for the -PVY-PVX treatment) (Fig. 2, Fig. 5). </text></annotation><annotation id="23577128_53"><infon key="gene">unc-29(172703)</infon><infon key="go-term">vulval location|GO:0034608</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="40476" length="311"/><location offset="40989" length="270"/><text>unc-29; acr-16 acr-18 mutants had a median contact response efficiency of 50% (cf. 50% for the -PVY-PVX treatment, Fig. 2), a median scanning speed of 140 microm/sec (cf. 110 microm/sec for the -PVY-PVX treatment) and a median loss of contact frequency of 2 (cf. 8 for the -PVY-PVX treatment) (Fig. 2, Fig. 5).  Like -PVY-PVX males, the triple mutant can still reverse in the context of mating, albeit inefficiently, suggesting that other ray-targeted pathways can partially compensate for the absence of PVY/PVX pathway activity and promote backward movement (see model in Fig. 6).</text></annotation><annotation id="23577128_54"><infon key="gene">acr-16(179235)</infon><infon key="go-term">vulval location|GO:0034608</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="40476" length="311"/><location offset="40989" length="270"/><text>unc-29; acr-16 acr-18 mutants had a median contact response efficiency of 50% (cf. 50% for the -PVY-PVX treatment, Fig. 2), a median scanning speed of 140 microm/sec (cf. 110 microm/sec for the -PVY-PVX treatment) and a median loss of contact frequency of 2 (cf. 8 for the -PVY-PVX treatment) (Fig. 2, Fig. 5).  Like -PVY-PVX males, the triple mutant can still reverse in the context of mating, albeit inefficiently, suggesting that other ray-targeted pathways can partially compensate for the absence of PVY/PVX pathway activity and promote backward movement (see model in Fig. 6).</text></annotation><annotation id="23577128_55"><infon key="gene">acr-18(191604)</infon><infon key="go-term">vulval location|GO:0034608</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="40476" length="311"/><location offset="40989" length="270"/><text>unc-29; acr-16 acr-18 mutants had a median contact response efficiency of 50% (cf. 50% for the -PVY-PVX treatment, Fig. 2), a median scanning speed of 140 microm/sec (cf. 110 microm/sec for the -PVY-PVX treatment) and a median loss of contact frequency of 2 (cf. 8 for the -PVY-PVX treatment) (Fig. 2, Fig. 5).  Like -PVY-PVX males, the triple mutant can still reverse in the context of mating, albeit inefficiently, suggesting that other ray-targeted pathways can partially compensate for the absence of PVY/PVX pathway activity and promote backward movement (see model in Fig. 6).</text></annotation></passage><passage><infon key="type">fig_title_caption</infon><offset>41260</offset><annotation id="23577128_56"><infon key="gene">acr-16(179235)</infon><infon key="go-term">male mating behavior|GO:0060179</infon><infon key="goevidence">NONE</infon><infon key="type">GOA</infon><location offset="41260" length="84"/><text>Male movement during mating depends on functionally redundant cholinergic receptors.</text></annotation><annotation id="23577128_57"><infon key="gene">acr-18(191604)</infon><infon key="go-term">male mating behavior|GO:0060179</infon><infon key="goevidence">NONE</infon><infon key="type">GOA</infon><location offset="41260" length="84"/><text>Male movement during mating depends on functionally redundant cholinergic receptors.</text></annotation><annotation id="23577128_58"><infon key="gene">unc-29(172703)</infon><infon key="go-term">male mating behavior|GO:0060179</infon><infon key="goevidence">NONE</infon><infon key="type">GOA</infon><location offset="41260" length="84"/><text>Male movement during mating depends on functionally redundant cholinergic receptors.</text></annotation></passage><passage><infon key="type">paragraph</infon><offset>43810</offset><annotation id="23577128_59"><infon key="gene">acr-16(179235)</infon><infon key="go-term">synaptic transmission, cholinergic|GO:0007271</infon><infon key="goevidence">NONE</infon><infon key="type">GOA</infon><location offset="45618" length="191"/><text>Third, the key receptors that mediate cholinergic neurotransmission in this pathway (encoded by acr-18, unc-29 and acr-16) appear to be preferentially expressed on the backward command cells.</text></annotation><annotation id="23577128_60"><infon key="gene">acr-18(191604)</infon><infon key="go-term">synaptic transmission, cholinergic|GO:0007271</infon><infon key="goevidence">NONE</infon><infon key="type">GOA</infon><location offset="45618" length="191"/><text>Third, the key receptors that mediate cholinergic neurotransmission in this pathway (encoded by acr-18, unc-29 and acr-16) appear to be preferentially expressed on the backward command cells.</text></annotation><annotation id="23577128_61"><infon key="gene">unc-29(172703)</infon><infon key="go-term">synaptic transmission, cholinergic|GO:0007271</infon><infon key="goevidence">NONE</infon><infon key="type">GOA</infon><location offset="45618" length="191"/><text>Third, the key receptors that mediate cholinergic neurotransmission in this pathway (encoded by acr-18, unc-29 and acr-16) appear to be preferentially expressed on the backward command cells.</text></annotation></passage><passage><infon key="type">title_2</infon><offset>64823</offset><annotation id="23577128_62"><infon key="gene">unc-29(172703)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="64823" length="70"/><text>Measurement of the Distance Moved in Response to ChR2-mediated PVY+PVX</text></annotation><annotation id="23577128_63"><infon key="gene">acr-16(179235)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="64823" length="70"/><text>Measurement of the Distance Moved in Response to ChR2-mediated PVY+PVX</text></annotation><annotation id="23577128_64"><infon key="gene">acr-18(191604)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="64823" length="70"/><text>Measurement of the Distance Moved in Response to ChR2-mediated PVY+PVX</text></annotation><annotation id="23577128_1"><infon key="gene">unc-29(172703)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="64823" length="70"/><text>Measurement of the Distance Moved in Response to ChR2-mediated PVY+PVX</text></annotation><annotation id="23577128_65"><infon key="gene">acr-16(179235)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="64823" length="70"/><text>Measurement of the Distance Moved in Response to ChR2-mediated PVY+PVX</text></annotation><annotation id="23577128_66"><infon key="gene">acr-18(191604)</infon><infon key="go-term">backward locomotion|GO:0043057</infon><infon key="goevidence">IGI</infon><infon key="type">GOA</infon><location offset="64823" length="70"/><text>Measurement of the Distance Moved in Response to ChR2-mediated PVY+PVX</text></annotation></passage></document></collection>
